What is the typical dose of Macrobid (nitrofurantoin) for treating a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin (Macrobid) Dosing for Urinary Tract Infection

For treating uncomplicated urinary tract infections (UTIs), the recommended dose of nitrofurantoin (Macrobid) is 100 mg twice daily for 5 days. 1

First-Line Treatment Options for UTI

Nitrofurantoin is considered a first-line treatment for uncomplicated cystitis along with:

  • Nitrofurantoin formulations and dosing:

    • Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5 days 1
    • Nitrofurantoin monohydrate or macrocrystals: 100 mg twice daily for 5 days 1
    • Nitrofurantoin macrocrystals prolonged release: 100 mg twice daily for 5 days 1
  • Other first-line options:

    • Fosfomycin trometamol: 3 g single dose 1
    • Pivmecillinam: 400 mg three times daily for 3-5 days 1

Evidence Supporting Nitrofurantoin for UTI

  • Nitrofurantoin has demonstrated efficacy in treating uncomplicated UTIs with clinical and microbiological cure rates significantly higher than placebo 2
  • The 5-day duration for nitrofurantoin is supported by multiple guidelines and has been shown to provide optimal balance between clinical efficacy and minimizing adverse effects 1
  • Nitrofurantoin achieves adequate urinary concentrations and provides reliable activity against common UTI pathogens 1

Special Considerations

  • Renal function: While some sources have historically cautioned against nitrofurantoin use in patients with reduced kidney function, evidence suggests it may still be effective in patients with mild to moderate reductions in estimated glomerular filtration rate 3
  • Pregnancy: Nitrofurantoin is generally considered safe during pregnancy except in the last trimester 1
  • Duration: While some international guidelines have suggested shorter courses (3 days), the strongest evidence supports a 5-day course for nitrofurantoin specifically 1, 4

Potential Adverse Effects

  • Common adverse effects include gastrointestinal disturbances and skin rash 1
  • Rare but serious adverse effects include pulmonary and hepatic toxicity (reported rates of 0.001% and 0.0003%, respectively) 1, 5
  • Long-term prophylactic use may increase risk of adverse effects 6

Follow-Up Recommendations

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1
  • If symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture with antimicrobial susceptibility testing should be performed 1
  • For recurrent UTIs (≥3 UTIs/year or ≥2 UTIs in 6 months), consider preventive strategies including non-antibiotic options 1

Alternative Treatments

  • For patients who cannot tolerate nitrofurantoin, alternative options include:
    • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days 1
    • Cephalosporins (e.g., cefadroxil): 500 mg twice daily for 3 days (if local E. coli resistance is <20%) 1

Remember that the choice of antimicrobial should be guided by local resistance patterns, patient-specific factors, and previous culture results when available 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Research

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

Macrodantin: a cautionary tale.

The Medical journal of Australia, 1986

Research

Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.